SCHEMBL19620536

SCHEMBL19620536

NC1=C(OS(=O)Cc2ccccc2)C(=O)C(c2cc(Cl)ccc2Cl)O1

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
DRD2 P14416 1/20 0.31
DRD3 P35462 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
KDM4E B2RXH2 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30
TRPV4 Q9HBA0 1/20 0.30
LMNA P02545 1/20 0.30
HTT P42858 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
CYP11B1 P15538 1/20 0.30
CYP11B2 P19099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620529 0.89 DPP4 (0.33) CYP1A2CYP3A4CYP2C19DRD2DRD3
SCHEMBL19620692 0.89 DPP4 (0.38) CYP1A2CYP3A4CYP2C19KDM4EPOLB
SCHEMBL22902028 0.85 HTR2A (0.34) CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL20367974 0.84 MAPT (0.41) RAB9AKDM4EPOLBMAPTLMNA
SCHEMBL20368252 0.83 MAPT (0.39) KDM4EPOLBMAPT
SCHEMBL19620595 0.83 KCNA5 (0.36) CYP1A2CYP3A4CYP2C19KDM4EPOLB
SCHEMBL19620538 0.83 KDM4E (0.37) CYP1A2CYP3A4CYP2C19KDM4EPOLB
SCHEMBL19620558 0.81 KDM4E (0.34) KDM4EPOLBMAPT
SCHEMBL19620597 0.80 DPP4 (0.38) CYP1A2CYP3A4CYP2C19DRD2DRD3
SCHEMBL19620621 0.80 MAPT (0.49) CYP1A2CYP3A4CYP2C19RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed